Structural characterization of a galactoglucomannan with anti-neuroinflammatory activity from Ganoderma lucidum.
Researchers isolated a polysaccharide from Ganoderma lucidum, GLP70-1-2, which improved spatial learning and memory, reduced anxiety in an Alzheimer's disease model, and decreased inflammatory factors in cells. GLP70-1-2 shows potential as a drug for Alzheimer's disease.
- Cao C et al (2024).
- Carbohydr Polym.
- PubMed:
- 38553228